India's Glenmark Life Sciences posts 25% rise in Q1 profit on API strength

Posted on:
Key Points

BENGALURU, July 21 (Reuters) - India's Glenmark Life Sciences (GLEM.NS) reported a near-25% rise in its first-quarter profit on Friday, led by robust growth of its mainstay active pharmaceutical ingredients (API) business in domestic as well as U.S. and European markets...

The Mumbai-based drug maker said profit stood at 1.35 billion rupees ($16.5 million) for the quarter ended June 30, compared with 1.09 billion rupees a year earlier...

The company, spun off from Glenmark Pharmaceuticals (GLEN.NS) in 2019 to focus on the API business, said total revenue from operations climbed 18% to 5.87 billion rupees during the quarter, with regulated markets including the U.S., Europe and India contributing 78%...

The drugmaker, whose clients include Aurobindo Pharma (ARBN.NS) and Torrent Pharmaceuticals (TORP.NS), also exports APIs to markets including Japan, Latin America and the Middle East...

You might be interested in

Escorts Kubota Q2 profit more than doubles on price hikes

03, Nov, 23

India Business News: Tractor maker Escorts Kubota reported a more than two-fold rise in the second-quarter profit on Friday, as price hikes offset muted sales. The company

'Post-it' maker 3M India's Q1 profit rises on robust demand

10, Aug, 23

3M India (TMIN.NS) reported an over 53% rise in first-quarter profit, aided by strong demand in its transportation and electronics and safety and industrial businesses.

Manforce condoms maker Mankind Pharma posts Q2 profit rise on higher sales

31, Oct, 23

India's Mankind Pharma (MNKI.NS) posted an over 19% rise in second-quarter profit on Tuesday, propelled by strong domestic sales and steady growth in the company's chronic drugs segment.

India's Glenmark Life Sciences posts Q3 profit rise; strong orderbook ahead, says CEO

23, Jan, 24

HYDERABAD (Reuters) - Indian drugmaker Glenmark Life Sciences posted a 13% rise in third-quarter profit on Tuesday, helped by a robust performance by its core active pharmaceutical ingredient (API)

India's Cyient beats Q2 revenue estimates on sustainability, transport demand

19, Oct, 23

India's Cyient (CYIE.NS) on Thursday reported a bigger-than-expected rise in its second-quarter revenue on strong growth in sustainability and transportation segments.

UPS to cut 12,000 jobs, explore options for Coyote business

30, Jan, 24

The company plans to cut $1 billion in costs as it comes off a ‘difficult and disappointing’ year, when volume, revenue and operating profit declined in all of its business segments, UPS CEO Carol Tome said

India’s economy seen losing speed as rising rates hurt demand

28, Feb, 23

Gross domestic product probably rose 4.7% last quarter from a year ago, according to a median estimate of economists in a Bloomberg survey ahead of data due Tuesday at 5:30 p.m. local time. That will be the slowest quarterly performance since the 4.09% expansion in the three months ended March last year.

‘Disappointed Again’: Ad Companies Suffer as Tech Firms Clip Spending

27, Oct, 23

A deep retrenchment in the tech sector again reverberated through the ad industry’s quarterly results.

Tata Consumer Q4 Results: Net profit rises 23% YoY to Rs 268 crore; dividend declared at 8.45/share

25, Apr, 23

Revenue growth mainly driven by underlying growth of 15% in India, 6% in international and 9% in non-branded businesses.

‘Post-it’ maker 3M India’s Q4FY23 profit rises 24% on strong demand

30, May, 23

3M India, which makes everything from 'Scotch' tape and 'Post-it' notes to power tools and medical products, has been raising prices to offset the hit from surging commodity costs.